OM vs. MCHP
OM (Outset Medical, Inc.) and MCHP (Microchip Technology Incorporated) are both stocks. OM operates in Medical Devices (Healthcare), while MCHP operates in Semiconductors (Technology). Over the past 5 years, OM returned -63.80%/yr vs 6.82%/yr for MCHP. At a 0.28 correlation, their price movements are largely independent.
Performance
OM vs. MCHP - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, OM achieves a 28.30% return, which is significantly lower than MCHP's 47.96% return.
OM
- 1D
- -2.46%
- 1M
- 10.19%
- YTD
- 28.30%
- 6M
- 43.37%
- 1Y
- -72.60%
- 3Y*
- -75.49%
- 5Y*
- -63.80%
- 10Y*
- —
MCHP
- 1D
- -9.20%
- 1M
- -0.18%
- YTD
- 47.96%
- 6M
- 44.27%
- 1Y
- 39.68%
- 3Y*
- 7.03%
- 5Y*
- 6.82%
- 10Y*
- 16.14%
OM vs. MCHP - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
OM Outset Medical, Inc. | 28.30% | -77.72% | -79.48% | -79.05% | -43.98% | -18.91% | 9.31% |
MCHP Microchip Technology Incorporated | 47.96% | 14.61% | -34.96% | 30.90% | -17.98% | 27.49% | 35.52% |
Correlation
The correlation between OM and MCHP is 0.27, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.27 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.23 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.28 |
Correlation (All Time) Calculated using the full available price history since Sep 15, 2020 | 0.28 |
Fundamentals
OM:
-$4.17
MCHP:
$0.43
OM:
0.73
MCHP:
8.03
OM:
$117.59M
MCHP:
$4.71B
OM:
$47.78M
MCHP:
$2.72B
OM:
-$62.73M
MCHP:
$1.02B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
OM vs. MCHP — Risk / Return Rank
OM
MCHP
OM vs. MCHP - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Outset Medical, Inc. (OM) and Microchip Technology Incorporated (MCHP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| OM | MCHP | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.60 | ||
| Sortino ratioReturn per unit of downside risk | -2.50 | ||
| Omega ratioGain probability vs. loss probability | 0.86 | 1.18 | -0.32 |
| Calmar ratioReturn relative to maximum drawdown | -0.86 | 1.16 | -2.02 |
| Martin ratioReturn relative to average drawdown | -1.12 | 3.06 | -4.18 |
Loading charts...
Drawdowns
OM vs. MCHP - Drawdown Comparison
The maximum OM drawdown since its inception was -99.67%, which is greater than MCHP's maximum drawdown of -63.77%. Use the drawdown chart below to compare losses from any high point for OM and MCHP.
Loading charts...
Drawdown Indicators
| OM | MCHP | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.67% | -63.77% | -35.90% |
Max Drawdown (1Y)Largest decline over 1 year | -84.88% | -34.41% | -50.47% |
Max Drawdown (3Y)Largest decline over 3 years | -99.05% | -63.77% | -35.28% |
Max Drawdown (5Y)Largest decline over 5 years | -99.64% | -63.77% | -35.87% |
Max Drawdown (10Y)Largest decline over 10 years | — | -63.77% | — |
Current DrawdownCurrent decline from peak | -99.50% | -9.20% | -90.30% |
Average DrawdownAverage peak-to-trough decline | -69.77% | -16.70% | -53.07% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 64.85% | 13.02% | +51.83% |
Volatility
OM vs. MCHP - Volatility Comparison
Outset Medical, Inc. (OM) has a higher volatility of 34.34% compared to Microchip Technology Incorporated (MCHP) at 20.70%. This indicates that OM's price experiences larger fluctuations and is considered to be riskier than MCHP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| OM | MCHP | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 34.34% | 20.70% | +13.64% |
Volatility (6M)Calculated over the trailing 6-month period | 68.20% | 34.78% | +33.42% |
Volatility (1Y)Calculated over the trailing 1-year period | 100.24% | 45.72% | +54.52% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 100.61% | 44.58% | +56.03% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 96.23% | 42.11% | +54.12% |
Dividends
OM vs. MCHP - Dividend Comparison
OM has not paid dividends to shareholders, while MCHP's dividend yield for the trailing twelve months is around 1.95%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
MCHP Microchip Technology Incorporated | 1.95% | 2.86% | 3.16% | 1.76% | 1.65% | 0.98% | 1.07% | 1.40% | 2.02% | 1.65% | 2.24% | 3.07% |
OM Outset Medical, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
OM vs. MCHP - Financials Comparison
This section allows you to compare key financial metrics between Outset Medical, Inc. and Microchip Technology Incorporated. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
OM vs. MCHP - Profitability Comparison
OM - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Outset Medical, Inc. reported a gross profit of 12.10M and revenue of 27.86M. Therefore, the gross margin over that period was 43.4%.
MCHP - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Microchip Technology Incorporated reported a gross profit of 967.30M and revenue of 1.31B. Therefore, the gross margin over that period was 73.8%.
OM - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Outset Medical, Inc. reported an operating income of -16.92M and revenue of 27.86M, resulting in an operating margin of -60.7%.
MCHP - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Microchip Technology Incorporated reported an operating income of 211.10M and revenue of 1.31B, resulting in an operating margin of 16.1%.
OM - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Outset Medical, Inc. reported a net income of -18.98M and revenue of 27.86M, resulting in a net margin of -68.1%.
MCHP - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Microchip Technology Incorporated reported a net income of 116.40M and revenue of 1.31B, resulting in a net margin of 8.9%.
Frequently Asked Questions
OM and MCHP have a correlation of 0.27, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
OM has higher volatility (34.34%) compared to MCHP (20.70%). In terms of maximum drawdown, OM dropped -99.67% vs MCHP's -63.77%.
MCHP currently has the higher Sharpe Ratio (0.87 vs -0.73), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for OM and MCHP
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer